DTB Podcast Titelbild

DTB Podcast

DTB Podcast

Von: BMJ Group
Jetzt kostenlos hören, ohne Abo

Saisonale Sparangebote | 0,99 € pro Monat für die ersten 3 Monate

Danach 6,99 €/Monat. Bedingungen gelten. Monatlich kündbar.

The Drug and Therapeutics Bulletin (DTB) Podcast is your source for practical, independent, and evidence-based information on drugs, medication, and prescribing.

Join host Hannah Harris (GP and DTB Clinical Editor) and Dr. Gordon Mallarkey (Editor-in-Chief) each month as they discuss the key highlights of the latest issue.

DTB - dtb.bmj.com - is published by BMJ Group, and offers rigorous, independent evaluations and practical advice on treatments and disease management for doctors, pharmacists, and healthcare professionals.

Subscribe to the DTB Podcast and get the latest drug and therapeutic insights.

Copyright 2023 All rights reserved. Hygiene & gesundes Leben
Folgen
  • When doctor becomes patient: levelling up the medical hierarchy

    When doctor becomes patient: levelling up the medical hierarchy
    Oct 22 2026

    The perspective on medical care changes when the doctor becomes a patient.

    In the October episode, host Dr Hannah Harris (DTB's Clinical Editor and GP) speaks with the newly appointed Editor-in-Chief, Dr Gordon Mallarkey, to introduce themselves to the DTB podcast listeners and discuss the latest edition of the journal.

    Hannah summarises her editorial about doctor-patient communication, reflecting on medical gaslighting and her personal experience as a breast cancer patient. They also discuss a drug review on Inbrija, an inhaled powder form of levodopa, used to treat intermittent 'OFF' motor episodes in Parkinson’s disease, and conclude with a review of spasticity management, covering non-pharmacological, oral, injectable, and surgical options.

    Read the issue on our website: https://dtb.bmj.com/content/64/10. We would love to hear from you with comments or questions via email (dtb@bmj.com), or you can find us on X with the handle @DTB_BMJ, and also LinkedIn and Facebook under “Pharmacy at BMJ Group”. The DTB Podcast is hosted by Hannah Harris. It is produced by Hannah Harris and Letícia Amorim. It is edited by Letícia Amorim.
    Mehr anzeigen Weniger anzeigen
    15 Min.
  • When medicines cause harm: learning from the DES disaster

    When medicines cause harm: learning from the DES disaster
    Sep 29 2026
    The DTB podcast returns with a new format, and a new host: Dr. Hannah Harris, urgent care GP and now Clinical Editor of DTB. In this episode, Hannah is joined by Professor Barbara Mintzes and Carol Devine, a patient and second-generation victim of Diethylstilbestrol (DES), to examine the long-term, multigenerational impacts of this synthetic oestrogen prescribed in pregnancy to prevent miscarriage from the 1940s to 1980s. They discuss why DES continued to be prescribed despite early proof of inefficacy and harm, Carol’s personal health struggle as a "DES Daughter," and the ongoing fight for government recognition and patient care. This episode also highlights key clinical updates from the September issue of the Drug and Therapeutics Bulletin, including a commentary by the new Editor-in-Chief, Dr. Gordon Mallarkey, on precision medicine in COPD, non-hormonal treatments for polyendocrine metabolic ovarian syndrome, diagnosis of spasticity, and continuous glucose monitoring in type 2 diabetes. Read the issue on our website: https://dtb.bmj.com/content/64/9. We would love to hear from you with comments or questions via email (dtb@bmj.com), or you can find us on X with the handle @DTB_BMJ, and also LinkedIn and Facebook under “Pharmacy at BMJ Group”. The DTB Podcast is hosted by Hannah Harris. It is produced by Hannah Harris and Letícia Amorim. It is edited by Letícia Amorim.
    Mehr anzeigen Weniger anzeigen
    35 Min.
  • Understanding clinical significance, and the new epinephrine nasal spray

    Understanding clinical significance, and the new epinephrine nasal spray
    Mar 23 2026
    In this podcast accompanying the March 2026 issue of the DTB (https://dtb.bmj.com/content/64/3), Syba Sunny (DTB Clinical Editor) is joined by Shivali Fulchand (Editorials and Education editor at The BMJ). Syba and Shivali discuss this month’s editorial on clinically important differences (https://dtb.bmj.com/content/64/3/34) and talk about why this is such an important topic. Then they go on to talk through the DTB’s drug review on the new adrenaline nasal spray that’s been formulated for the treatment of anaphylaxis (https://dtb.bmj.com/content/64/3/36). Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us, please email dtb@bmj.com. Thank you for listening.
    Mehr anzeigen Weniger anzeigen
    19 Min.
adbl_web_anon_alc_button_suppression_t1
Noch keine Rezensionen vorhanden